Why is Brooklyn ImmunoTherapeutics, Inc. (BTX) stock falling today?
Shares of the Brooklyn ImmunoTherapeutics, Inc. (BTX) were down in the current market today amid the spread of the news of the acquisition of a license for its mRNA technology platform. It seems that profit-takers have stepped in as BTX stock price saw a downtrend of 13.45% to drop at $37.85 a share at the […]
Why is Brooklyn ImmunoTherapeutics, Inc. (BTX) stock falling today? Read More »